Seasonal Influenza Vaccines - Current and Future Players
Albany, New York, Feb 02, 2017
"Seasonal
Influenza Vaccines - Current and Future Players"
The Report covers current Industries Trends, Worldwide Analysis,
Global Forecast, Review, Share, Size, Growth, Effect.
Description-
GlobalData
has released its pharma report, Seasonal Influenza Vaccines - Current
and Future Players. The report is a vital source of up-to-date
information with in-depth analysis on the companies in the rapidly
growing Seasonal Influenza Vaccines Market. The report identifies and
analyses the key companies shaping and driving the global Seasonal
Influenza Vaccines market. The report provides insight into the
competitive Seasonal Influenza Vaccines landscape, including new
companies entering the market. This report is built using data and
information sourced from proprietary databases, primary and secondary
and in-house analysis by GlobalDatas team of industry experts.
*
Scope
- Investigation of current and future market competition for Seasonal Influenza Vaccines
- Competitor assessment
- Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
- Strategic assessment of Seasonal Influenza Vaccines sector through market impact analysis, future market scenario and company analysis
* Reasons to buy
- Gain a high level view of the trends shaping and driving Seasonal Influenza Vaccines market
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market
- Whats the next big thing in the global Seasonal Influenza Vaccines market landscape? Identify, understand and capitalize
- Investigation of current and future market competition for Seasonal Influenza Vaccines
- Competitor assessment
- Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
- Strategic assessment of Seasonal Influenza Vaccines sector through market impact analysis, future market scenario and company analysis
* Reasons to buy
- Gain a high level view of the trends shaping and driving Seasonal Influenza Vaccines market
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market
- Whats the next big thing in the global Seasonal Influenza Vaccines market landscape? Identify, understand and capitalize
*
Table of Contents
1
Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Introduction 5
2.1 Catalyst 5
2.2 Related Reports 6
2.3 Upcoming Related Reports 6
1.1 List of Tables 4
1.2 List of Figures 4
2 Introduction 5
2.1 Catalyst 5
2.2 Related Reports 6
2.3 Upcoming Related Reports 6
3
Market Outlook 7
3.1 Global Markets 7
3.1.1 Forecast 7
3.1.2 Drivers and Barriers - Global Issues 13
3.1 Global Markets 7
3.1.1 Forecast 7
3.1.2 Drivers and Barriers - Global Issues 13
4
Current and Future Players 14
4.1 Overview 14
4.2 Trends in Corporate Strategy 18
4.3 Company Profiles - Major Players 21
4.3.1 Sanofi 21
4.3.2 CSL Limited (Seqirus) 23
4.3.3 GlaxoSmithKline 25
4.3.4 AstraZeneca (MedImmune) 26
4.3.5 Protein Sciences Corporation 29
4.3.6 Mitsubishi Tanabe Pharma 31
4.3.7 Novavax 32
4.4 Other Companies 34
4.4.1 Mylan 34
4.4.2 Daiichi Sankyo 35
4.1 Overview 14
4.2 Trends in Corporate Strategy 18
4.3 Company Profiles - Major Players 21
4.3.1 Sanofi 21
4.3.2 CSL Limited (Seqirus) 23
4.3.3 GlaxoSmithKline 25
4.3.4 AstraZeneca (MedImmune) 26
4.3.5 Protein Sciences Corporation 29
4.3.6 Mitsubishi Tanabe Pharma 31
4.3.7 Novavax 32
4.4 Other Companies 34
4.4.1 Mylan 34
4.4.2 Daiichi Sankyo 35
5
Appendix 36
5.1 Bibliography 36
5.2 Abbreviations 74
5.3 Methodology 78
5.4 Forecasting Methodology 78
5.4.1 Vaccine Coverage 78
5.4.2 Vaccines Included 79
5.4.3 Key Launch Dates 79
5.4.4 Influenza Vaccine Tender System Assumptions 80
5.4.5 General Pricing Assumptions 81
5.4.6 Individual Vaccine Assumptions 82
5.4.7 Pricing of Pipeline Agents 90
5.5 Primary Research - KOLs Interviewed for this Report 91
5.6 Primary Research - Prescriber Survey 94
5.7 About the Authors 95
5.7.1 Analyst 95
5.7.2 Therapy Area Director 95
5.7.3 Epidemiologists 96
5.7.4 Director of Epidemiology 97
5.7.5 Global Director of Therapy Analysis and Epidemiology 97
5.8 About GlobalData 98
5.9 Disclaimer 98
5.1 Bibliography 36
5.2 Abbreviations 74
5.3 Methodology 78
5.4 Forecasting Methodology 78
5.4.1 Vaccine Coverage 78
5.4.2 Vaccines Included 79
5.4.3 Key Launch Dates 79
5.4.4 Influenza Vaccine Tender System Assumptions 80
5.4.5 General Pricing Assumptions 81
5.4.6 Individual Vaccine Assumptions 82
5.4.7 Pricing of Pipeline Agents 90
5.5 Primary Research - KOLs Interviewed for this Report 91
5.6 Primary Research - Prescriber Survey 94
5.7 About the Authors 95
5.7.1 Analyst 95
5.7.2 Therapy Area Director 95
5.7.3 Epidemiologists 96
5.7.4 Director of Epidemiology 97
5.7.5 Global Director of Therapy Analysis and Epidemiology 97
5.8 About GlobalData 98
5.9 Disclaimer 98
Comments
Post a Comment